ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 602617 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 602617; 2) Community: the network communities that were significantly associated with the response to NSC 602617; 3) Molecule: the relationships between components within communities and NSC 602617; 4) MDR: the compounds that were significantly associated with the NSC 602617.

NSC Compound Enrichment Correlation
NSC 328410 Camptothecin Derivative 0.0297837393005855 0.022154194
NSC 685828 7H-Purine, 6-chloro-7-[2-deoxy-3-O-(4-methylphenyl)- 4-(4-methylphenoxy)-.beta.-D-erythrofuranosyl]- 0.0297837393005856 -0.1460391
NSC 701743 Null 0.0297837393005856 0.031938188
NSC 721154 11-Cyanomethylen-2-methoxy-6-methyl-11H-indolo[1,2-b]indazol ium trifluoromethanesulfonate 0.0297837393005856 -0.039090731
NSC 736624 Indenoisoquinoline derivative 0.0297837393005856 0.0078438609
NSC 135037 Jatrophone 0.0297837393005859 -0.029944866
NSC 656243 Benzo[1,2-b:5,4-b']dithiophene-2-carboxylic acid, 4,8-dioxo- 0.0297837393005859 0.65899509
NSC 658257 Naphthalen-2-one, 4-[(4-bromophenyl)amino]-1,2-dihydro-1-(hydroxyimino)- 0.0297837393005859 0.68007144
NSC 682352 Null 0.0297837393005859 -0.25633043
NSC 701666 Benzenamine, N-[4-(4-chlorophenyl)-3-(2-propenyl)- 2(3H)-thiazolylidene]-2-methoxy-, hydrobromide, (2Z)- 0.0297837393005859 0.24328001
Total:53  Current:31    [First] [Prev] [Next] [Last]